The effects of resveratrol on vasospasm after experimental subarachnoidal hemorrhage in rats

Surgical Neurology

Volumn 70, Issue 4, 2008, Pages 337-343

  Karaoglan, Alper ^a   Akdemir, Osman ^a   Barut, Seref ^a   Kokturk, Sibel ^b   Uzun, Hafize ^b   Tasyurekli, Mustafa ^b   Colak, Ahmet ^c  

^a ISTANBUL TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

^c MALTEPE UNIVERSITY   (Turkey)

Author keywords

Basilar artery; Cerebral vasospasm; Endothelin 1; Lipid peroxidation; Resveratrol; Superoxide dismutase

Indexed keywords

BIOCHEMICAL MARKER; ENDOTHELIN 1; LIPID; RESVERATROL; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL WALL THICKNESS; ARTICLE; BASILAR ARTERY; BLOOD AUTOTRANSFUSION; BRAIN TISSUE; BRAIN VASOSPASM; CISTERNA MAGNA; CONTROLLED STUDY; DISEASE MODEL; DRUG EFFECT; DRUG EFFICACY; GRAPE; LIPID BLOOD LEVEL; LIPID PEROXIDATION; MICROSCOPY; NEUROPROTECTION; NONHUMAN; RAT; RED WINE; SHAM PROCEDURE; SINGLE DRUG DOSE; SUBARACHNOID HEMORRHAGE; TREATMENT RESPONSE;

ANIMALS; ANTIOXIDANTS; BASILAR ARTERY; ENDOTHELIN-1; INJECTIONS, INTRAVENOUS; LIPID PEROXIDATION; MUSCLE, SMOOTH, VASCULAR; RATS; RATS, WISTAR; STILBENES; SUBARACHNOID HEMORRHAGE; SUPEROXIDE DISMUTASE; VASODILATION; VASOSPASM, INTRACRANIAL; VERTEBROBASILAR INSUFFICIENCY;

EID: 51349111445     PISSN: 00903019     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surneu.2007.07.031     Document Type: Article

References (44)

1. Bertelli A.A., Giovannini L., Bernini W., et al. Antiplatelet activity of cis-resveratrol. Drugs Exp Clin Res 22 (1996) 61-63
2. Bertelli A.A., Giovannini L., Giannessi D., et al. Antiplatelet activity of synthetic and natural resveratrol in red wine. Int J Tissue React 17 (1995) 1-3
3. Buege J.A., and Aust S.D. Microsomal lipid peroxidation. Methods Enzymol 52 (1978) 302-310
4. Chow M., Dumont A.S., and Kassell N.F. Endothelin receptor antagonists and cerebral vasospasm: an update. Neurosurgery 51 (2002) 1333-1341
5. Delgado T.J., Brismar J., and Svendgaard N.A. Subarachnoid haemorrhage in the rat: angiography and fluorescence microscopy of the major cerebral arteries. Stroke 16 (1985) 595-602
6. Dobrydneva Y., Williams R.L., and Blackmore P.F. trans-Resveratrol inhibits calcium influx in thrombin-stimulated human platelets. Br J Pharmacol 128 (1999) 149-157
7. Faraci F.M., and Heistad D.D. Regulation of the cerebral circulation: role of endothelium and potassium channels. Physiol Rev 78 (1998) 53-97
8. Fauconneau B., Waffo-Teguo P., Huguet F., et al. Comparative study of radical scavenger and antioxidant properties of phenolic compounds from Vitis vinifera cell cultures using in vitro tests. Life Sci 61 (1997) 2103-2110
9. Findlay J.M., Macdonald R.L., and Weir B.K. Current concepts of pathophysiology and management of cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Cerebrovasc Brain Metab Rev 3 (1991) 336-361
10. Fremont L. Biological effects of resveratrol. Life Sci 66 (2000) 663-673
11. Gaetani P., Pasqualin A., Rodriguez y Baena R., et al. Oxidative stress in the human brain after subarachnoid hemorrhage. J Neurosurg 89 (1998) 748-754
12. Giovannini L., Migliori M., Longoni B.M., et al. Resveratrol, a polyphenol found in wine, reduces ischemia reperfusion injury in rat kidneys. J Cardiovasc Pharmacol 37 (2001) 262-270
13. Han Y.S., Zheng W.H., Bastianetto S., et al. Neuroprotective effects of resveratrol against beta-amyloid-induced neurotoxicity in rat hippocampal neurons: involvement of protein kinase C. Br J Pharmacol 141 (2004) 997-1005
14. Hansen-Schwartz J, Hoel NL, Zhou M, et al. Subarachnoid hemorrhage enhances endothelin receptor expression and function in rat cerebral arteries. Neurosurgery 2003;52:1188-94, 1194-5.
15. Huang S.S., Tsai M.C., Chih C.L., et al. Resveratrol reduction of infarct size in Long-Evans rats subjected to focal cerebral ischemia. Life Sci 69 (2001) 1057-1065
16. Jager U., and Nguyen-Duong H. Relaxant effect of trans-resveratrol on isolated porcine coronary arteries. Arzneimittelforschung 49 (1999) 207-211
17. Kamii H., Kato I., Kinouchi H., et al. Amelioration of vasospasm after subarachnoid hemorrhage in transgenic mice overexpressing CuZn-superoxide dismutase. Stroke 30 (1999) 867-871
18. Kessler I.M., Pacheco Y.G., Lozzi S.P., et al. Endothelin-1 levels in plasma and cerebrospinal fluid of patients with cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Surg Neurol 64 Suppl 1 (2005) S1:2-S1:5 [discussion S1:5]
19. Li H.F., Chen S.A., and Wu S.N. Evidence for the stimulatory effect of resveratrol on Ca(2+)-activated K+ current in vascular endothelial cells. Cardiovasc Res 45 (2000) 1035-1045
20. Lin C.L., Jeng A.Y., Howng S.L., et al. Endothelin and subarachnoid hemorrhage-induced cerebral vasospasm: pathogenesis and treatment. Curr Med Chem 11 (2004) 1779-1791
21. Liu J.C., Chen J.J., Chan P., et al. Inhibition of cyclic strain-induced endothelin-1 gene expression by resveratrol. Hypertension 42 (2003) 1198-1205
22. Macdonald R.L., Weir B.K., Runzer T.D., et al. Malondialdehyde, glutathione peroxidase, and superoxide dismutase in cerebrospinal fluid during cerebral vasospasm in monkeys. Can J Neurol Sci 19 (1992) 326-332
23. Macdonald R.L., and Weir B.K. Cerebral vasospasm and free radicals. Free Radic Biol Med 16 (1994) 633-643
24. Marier J.F., Vachon P., Gritsas A., et al. Metabolism and disposition of resveratrol in rats: extent of absorption, glucuronidation, and enterohepatic recirculation evidenced by a linked-rat model. J Pharmacol Exp Ther 302 (2002) 369-373
25. McGirt M.J., Parra A., Sheng H., et al. Attenuation of cerebral vasospasm after subarachnoid hemorrhage in mice overexpressing extracellular superoxide dismutase. Stroke 33 (2002) 2317-2323
26. Novakovic A., Gojkovic-Bukarica L., Peric M., et al. The mechanism of endothelium-independent relaxation induced by the wine polyphenol resveratrol in human internal mammary artery. J Pharmacol Sci 101 (2006) 85-90
27. Ohkuma H., Ogane K., Fujita S., et al. Impairment of anti-platelet-aggregating activity of endothelial cells after experimental subarachnoid hemorrhage. Stroke 24 (1993) 1541-1545 [discussion 1545-6]
28. Orsini F., Pelizzoni F., Verotta L., et al. Isolation, synthesis, and antiplatelet aggregation activity of resveratrol 3-O-beta-d-glucopyranoside and related compounds. J Nat Prod 60 (1997) 1082-1087
29. Sakaki S., Kuwabara H., and Ohta S. Biological defence mechanism in the pathogenesis of prolonged cerebral vasospasm in the patients with ruptured intracranial aneurysms. Stroke 17 (1986) 196-202
30. Sakaki S., Ohta S., Nakamura H., et al. Free radical reaction and biological defense mechanism in the pathogenesis of prolonged vasospasm in experimental subarachnoid hemorrhage. J Cereb Blood Flow Metab 8 (1988) 1-8
31. Sasaki T., Wakai S., Asano T., et al. The effect of a lipid hydroperoxide of arachidonic acid on the canine basilar artery. An experimental study on cerebral vasospasm. J Neurosurg 54 (1981) 357-365
32. Seifert V., Loffler B.M., Zimmermann M., et al. Endothelin concentrations in patients with aneurysmal subarachnoid hemorrhage. Correlation with cerebral vasospasm, delayed ischemic neurological deficits, and volume of hematoma. J Neurosurg 82 (1995) 55-62
33. Sercombe R., Dinh Y.R., and Gomis P. Cerebrovascular inflammation following subarachnoid hemorrhage. Jpn J Pharmacol 88 (2002) 227-249
34. Sharma M., and Gupta Y.K. Chronic treatment with trans resveratrol prevents intracerebroventricular streptozotocin induced cognitive impairment and oxidative stress in rats. Life Sci 71 (2002) 2489-2498
35. Shishido T., Suzuki R., Qian L., et al. The role of superoxide anions in the pathogenesis of cerebral vasospasm. Stroke 25 (1994) 864-868
36. Sun Y., Oberley L.W., and Li Y. A simple method for clinical assay of superoxide dismutase. Clin Chem 34 (1988) 497-500
37. Suzuki R., Masaoka H., Hirata Y., et al. The role of endothelin-1 in the origin of cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg 77 (1992) 96-100
38. Tadolini B., Juliano C., Piu L., et al. Resveratrol inhibition of lipid peroxidation. Free Radic Res 33 (2000) 105-114
39. Vatter H., Zimmermann M., Tesanovic V., et al. Cerebrovascular characterization of clazosentan, the first nonpeptide endothelin receptor antagonist clinically effective for the treatment of cerebral vasospasm. Part I: inhibitory effect on endothelin (A) receptor-mediated contraction. J Neurosurg 102 (2005) 1101-1107
40. Vatter H., Zimmermann M., Tesanovic V., et al. Cerebrovascular characterization of clazosentan, the first nonpeptide endothelin receptor antagonist shown to be clinically effective for the treatment of cerebral vasospasm. Part II: effect on endothelin (B) receptor-mediated relaxation. J Neurosurg 102 (2005) 1108-1114
41. Voldby B., and Enevoldsen E.M. Intracranial pressure changes following aneurysm rupture. Part 2: associated cerebrospinal fluid lactacidosis. J Neurosurg 56 (1982) 197-204
42. Yang Y.B., and Piao Y.J. Effects of resveratrol on secondary damages after acute spinal cord injury in rats. Acta Pharmacol Sin 24 (2003) 703-710
43. Zimmermann M., Jung C.S., Vatter H., et al. Effect of endothelin-converting enzyme inhibitors on big endothelin-1 induced contraction in isolated rat basilar artery. Acta Neurochir (Wien) 144 (2002) 1213-1219
44. Zimmermann M., and Seifert V. Endothelin and subarachnoid hemorrhage: an overview. Neurosurgery 43 (1998) 863-875 [discussion 875-6]